1. Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.48
Figure 3 Therapies effective for treating both cardiovascular disease (CVD) and chronic kidney disease (CKD)
Figure 3 | Therapies effective for treating both cardiovascular disease (CVD) and chronic kidney disease (CKD). Drugs that improve blood-pressure (BP) control, lipid control, and inhibit the renin–angiotensin–aldosterone system (RAAS) can offer cardiorenal protection in patients with CKD. However, many caveats exist to using these drugs in CKD, including increased risk of hyperkalaemia. ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin-receptor blocker; eGFR, estimated glomerular filtration rate; HFrEF, heart failure with reduced ejection fraction; MRA, mineralocorticoid-receptor antagonist.
Ruiz-Hurtado, G. et al. (2016) Global cardiovascular protection in chronic kidney disease
Nat. Rev. Cardiol. doi: /nrcardio